Press Releases

Press Releases

May 10, 2023
Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results
CANTON, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported
March 27, 2023
Organogenesis Applauds Findings from the Office of Inspector General
Transitioning all skin substitutes to ASP-based payments has the potential to substantially reduce Medicare Part B expenditures CANTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development,


Shareholder Tools